Skip to main content
. 2017 Oct 21;174(Suppl Suppl 1):S17–S129. doi: 10.1111/bph.13878
Nomenclature C3a receptor C5a 1 receptor C5a 2 receptor
HGNC, UniProt C3AR1, Q16581 C5AR1, P21730 C5AR2, Q9P296
Potency order of endogenous ligands C3a (C3, P01024) >C5a (C5, P01031) [41] C5a (C5, P01031), C5a des‐Arg (C5) >C3a (C3, P01024) [41]
Endogenous agonists ribosomal protein S19 (RPS19, P39019) [2160]
Agonists E7 [43], compound 17 [1644], compound 21 [1643], Ac‐RHYPLWR [707] N‐methyl‐Phe‐Lys‐Pro‐D‐Cha‐Cha‐D‐Arg‐CO 2H [959, 1035]
Selective agonists P59 (Biased agonist) [396], P32 (Biased agonist) [396]
Antagonists SB290157 (pIC50 7.6) [40], compound 4 (pIC50 5.9) [1643] avacopan (pIC50 9.7) [125], W54011 (pK i 8.7) [1893], DF2593A (pIC50 8.3) [1380], AcPhe‐Orn‐Pro‐D‐Cha‐Trp‐Arg (pIC50 7.9) [2128], N‐methyl‐Phe‐Lys‐Pro‐D‐Cha‐Trp‐D‐Arg‐CO 2H (pIC50 7.2) [1035]
Labelled ligands [125 I]C3a (human) (Agonist) [310] [125 I]C5a (human) (Agonist) [843] [125 I]C5a (human) (Agonist)